Mahmoud Abunasser
Amman, AM 11942, Jordan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Comparative Evaluation of Risk Assessment Models for Predicting Venous Thromboembolic Events in Cancer Patients with Implanted Central Venous Access Devices.
Journal: Cancers
Published: August 28, 2025
Prevalence and predictors of do-not-resuscitate orders among advanced cancer patients receiving palliative care at a tertiary cancer center in Jordan: a 10-year retrospective analysis.
Journal: BMC palliative care
Published: August 26, 2025
Exploring Patients' and Families' Perceptions of Family Meetings in Oncology: A Qualitative Study.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: May 25, 2025
Clinical Outcomes of Patients Treated with Ribociclib in Combination with Aromatase Inhibitors or Fulvestrant for HR-Positive, HER2-Negative Metastatic Breast Cancer, Real-World Data from a Low-Resourced Country.
Journal: ImmunoTargets and therapy
Published: July 16, 2024
Update in the clinical utilization of chemoprevention for breast cancer: a narrative review.
Journal: Frontiers in oncology
Published: May 20, 2024
Establishment of a clinical cancer genetics program for breast cancer in a resource-limited country; challenges and opportunities.
Journal: Frontiers in oncology
Published: May 13, 2024
Aggressiveness of Cancer Care at End of Life in Patients with Metastatic Breast Cancer in Jordan.
Journal: Journal of multidisciplinary healthcare
Published: June 16, 2023
Urinary bladder metastasis from primary breast cancer, a rare and challenging diagnosis. A case report and literature review.
Journal: Annals of medicine and surgery (2012)
Published: January 28, 2022
Thromboembolic Events in Patients with HER2-Negative, Hormone Receptor-Positive, Metastatic Breast Cancer Treated with Ribociclib Combined with Letrozole or Fulvestrant: A Real-World Data.
Journal: Cancer management and research
Published: December 11, 2021
Vitiligo-Like Lesions in a Patient with Metastatic Breast Cancer Treated with Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor: A Case Report and Literature Review.
Journal: Clinical, cosmetic and investigational dermatology
Published: October 17, 2021
Patterns and Prevalence of BRCA1 and BRCA2 Germline Mutations Among Patients with Triple-Negative Breast Cancer: Regional Perspectives.
Journal: Cancer management and research
Published: April 19, 2021
Last Updated: 09/26/2026